This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naas, T.
Right arrow Articles by Nordmann, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naas, T.
Right arrow Articles by Nordmann, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2001, p. 2908-2915, Vol. 45, No. 10
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.10.2908-2915.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

AmpD Is Required for Regulation of Expression of NmcA, a Carbapenem-Hydrolyzing beta -Lactamase of Enterobacter cloacae

Thierry Naas,* Sandrine Massuard, Fabien Garnier, and Patrice Nordmann

Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Paris-Sud, 94275 Le Kremlin-Bicêtre, France

Received 21 February 2001/Returned for modification 23 June 2001/Accepted 26 July 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

To further elucidate the induction process of the carbapenem-hydrolyzing beta -lactamase of Ambler class A, NmcA, ampD genes of the wild-type (WT) strain and of ceftazidime-resistant mutants of Enterobacter cloacae NOR-1 were cloned and tested in transcomplementation experiments. Ceftazidime-resistant E. cloacae NOR-1 mutants exhibited derepressed expression of the AmpC-type cephalosporinase and of the carbapenem-hydrolyzing beta -lactamase NmcA. The ampD genes of Escherichia coli and E. cloacae WT NOR-1 transcomplemented the ceftazidime-resistant E. cloacae NOR-1 mutants to the WT level of beta -lactamase expression, while the mutated ampD alleles of E. cloacae NOR-1 failed to do so. The deduced E. cloacae NOR-1 WT AmpD protein exhibited 95 and 91% amino acid identity with the E. cloacae O29 and E. cloacae 14 WT AmpD proteins, respectively. Of the 12 ceftazidime-resistant E. cloacae NOR-1 strains, 3 had AmpD proteins with amino acid changes, while the others had truncated AmpD proteins. Most of these mutations were located outside the conserved regions that link the AmpD proteins to the cell wall hydrolases. AmpD from E. cloacae NOR-1 is involved in the regulation of expression of both beta -lactamases (NmcA and AmpC), suggesting that structurally unrelated genes may be under the control of an identical genetic system.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

Several enterobacterial species express inducible, chromosomally encoded AmpC-type beta -lactamases (cephalosporinase) (11, 37), which are class C enzymes according to Ambler's classification (2). The regulation of AmpC beta -lactamase expression is intimately linked to cell wall recycling and involves at least three genes: ampR, which encodes a transcriptional regulator of the LysR family; ampG, which encodes a transmembrane permease; and ampD, which encodes a cytosolic N-acetyl-anhydromuramyl-L-alanine amidase hydrolyzing 1,6-anhydromuropeptides (11, 12, 15, 16, 19, 31). In the absence of beta -lactam inducer, AmpR is repressed by the murein precursor UDP- MurNAc-pentapeptide (uridine-pyrophosphoryl-N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid-D-alanyl-D-alanine) (14). Since beta -lactams interfere with murein synthesis, their actions lead to an increased periplasmic accumulation of degradation products, such as 1,6-anhydromuropeptides, which are signal molecules for beta -lactamase induction (8, 15). AmpG transports these products from periplasm to cytoplasm, where they are cleaved by AmpD, which acts as a negative regulator of AmpC beta -lactamase expression (8, 15, 19, 31). In ampD mutants, the constitutive overproduction of AmpC beta -lactamase is associated with an accumulation of an M tripeptide (monosaccharide tripeptide) (1,6-anhydro-N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid) and an M pentapeptide (1,6-anhydro-N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid-D-alanyl-D-alanine) in the cytoplasm (8, 15). Jacobs et al. suggested that the M tripeptide could be the AmpR-activating ligand, since this product can relieve the repressed state of AmpR in vitro, resulting in the activation of beta -lactamase expression (14). However, potential interactions of the M pentapeptide with AmpR have not been investigated. Another gene, ampE, which encodes a transmembrane protein, forms an operon with ampD, but this gene is not involved in beta -lactamase expression (11, 13, 32).

Several chromosomally mediated Ambler class A beta -lactamases are regulated in a manner similar to AmpC. In Proteus vulgaris, the chromosomal class A beta -lactamase CumA is under the control of CumR, a LysR-type regulator, and is dependent on the presence of CumD (an AmpD analog) and CumG (an AmpG analog) for its induction (7). Similar observations have been made for Citrobacter koseri (formerly Citrobacter diversus) where CdiA, a class A beta -lactamase, is under the control of CdiR (17) and for Burkholderia cepacia, which expresses a class A beta -lactamase, PenA, that is under the control of a transcriptional regulator, PenR (41). Serratia fonticola expresses an inducible oxyimino cephalosporin-hydrolyzing class A beta -lactamase named SFO-1 (33). This enzyme was recently found to be plasmid mediated in Enterobacter cloacae 8009 and regulated by an AmpR-type regulator (24). An inducible beta -lactamase from Proteus penneri that is closely related to class A beta -lactamases from a biochemical point of view has been described (25).

In E. cloacae NOR-1, in addition to the inducible AmpC beta -lactamase that is under the control of the transcriptional regulator AmpR (29, 30), a second beta -lactamase, NmcA, had been identified (30). NmcA, unlike most carbapenem-hydrolyzing beta -lactamases that are involved in acquired carbapenem resistance, belongs to Ambler class A (26). NmcA expression is also regulated by the presence of a LysR-type regulator, NmcR, which is necessary for NmcA expression and induction (26, 30). To further elucidate the NmcA induction process, ampD genes of the wild-type (WT) NOR-1 strain and of ceftazidime-resistant E. cloacae NOR-1 (NOR-1D) mutants were cloned and tested in transcomplementation experiments. Furthermore, the inducibility of NmcA expression was tested when nmcA and nmcR were located on a plasmid at different copy numbers.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

Bacterial strains, antimicrobial agents, and MIC determinations. The strains and plasmids used in this study are described in Table 1. Electrocompetent Escherichia coli DH10B (Life Technologies, Eragny, France) was used as host for construction and propagation of recombinant plasmids. Electrocompetent E. coli MC4100, E. coli JRG582, E. cloacae MHN1, E. cloacae MHN2, and E. cloacae NOR-1 variants were prepared as described previously (34). Bacterial cells were grown in Trypticase Soy (TS) broth or on TS agar plates (Sanofi Diagnostics Pasteur, Marnes-La-Coquette, France). When required, kanamycin (50 µg/ml), chloramphenicol (30 µg/ml), and spectinomycin (50 µg/ml) were added.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Bacterial strains and plasmids used in this study

Routine antibiograms were determined by the disk diffusion method on Mueller-Hinton (MH) agar plates (Sanofi Diagnostics Pasteur). The antimicrobial agents and their sources have been described elsewhere (27, 30). MICs of selected beta -lactams were determined by an agar dilution technique on MH agar plates with a Steers multiple inoculator and an inoculum of 104 CFU per spot (27, 30, 34). All plates were incubated at 37°C for 18 h. MICs of beta -lactams were determined alone or with a fixed concentration of either clavulanic acid (2 µg/ml) or tazobactam (4 µg/ml). MIC results were interpreted according to the National Committee for Clinical Laboratory Standards guidelines (28).

In vitro selection of extended-spectrum cephalosporin-resistant mutants. Frequencies of in vitro selection of antibiotic-resistant mutants were determined by counting the number of colonies that arose by plating a large inoculum (109 CFU) of E. cloacae NOR-1 on MH agar plates containing ceftazidime (32 µg/ml).

Kinetic measurements. beta -Lactamase extracts were obtained as described previously (34). The specific beta -lactamase activity of the extracts was measured by UV spectrophotometry (ULTROSPEC 2000 spectrophotometer; Amersham Pharmacia Biotech, Orsay, France) as described previously (34). Basal and induced beta -lactamase levels were determined as previously described (34). beta -Lactamase activity was induced with imipenem (10 µg/ml) and cefoxitin (2 µg/ml for E. cloacae WT NOR-1 and 50 µg/ml for ceftazidime-resistant E. cloacae NOR-1D mutants). The specific beta -lactamase activities were obtained as previously described with cephalothin and imipenem as substrates (30, 34). One unit of enzyme activity was defined as the activity which hydrolyzes 1 µmol of cephalothin or imipenem per min. The total protein content was measured with the Bio-Rad DC protein assay kit (Bio-Rad, Ivry/Seine, France).

Hydridization, PCR analyses, and sequencing. Standard PCR experiments were performed as described previously (36). All the PCR amplifications were performed using the following amplification program: 10 min at 94°C; 35 cycles, with 1 cycle consisting of 1 min at 94°C, 1 min at 55°C, and 3 min at 72°C; followed by a final extension step of 10 min at 72°C. In order to PCR amplify the ampD genes of E. cloacae WT NOR-1 and mutant strains, two primers derived from the E. cloacae O-14 ampD sequence (18, 23) were synthesized. The sequences of the primers were as follows: AmpDF, 5'-ATGTTGTTAGAAAACGGATG-3'; and AmpDB, 5'-TCATGTTATCTCCTTATCTG-3'. A 564-bp DNA fragment encompassing the entire ampD gene was amplified by PCR with the Taq DNA polymerase (PE Biosystems, Les Ulis, France) and whole-cell DNAs of E. cloacae WT NOR-1 and E. cloacae NOR-1D mutants.

The amplicons were purified using the Qiaquick PCR purification kit (Qiagen). The nucleotide and amino acid sequences were analyzed using the software available at the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov). Multiple-sequence alignment of deduced peptide sequences was performed online at the University of Cambridge website using the ClustalW program (http://www.ebi.uk/clustallW).

In order to screen for the presence of the ampD gene in E. cloacae NOR-1D mutants that were negative by PCR analysis, 2-µg samples of heat-denatured whole-cell DNAs were spotted onto a nylon membrane (Hybond N+; Amersham Pharmacia Biotech) and were subsequently UV cross-linked for 2 min (UV cross-linker; Stratagene, Amsterdam, The Netherlands). Hybridizations were performed as described by the manufacturer using the enhanced chemiluminescence nonradioactive labeling and detection kit (Amersham Pharmacia Biotech). The probe consisted of a 564-bp ampD PCR fragment from plasmid pMS13 (Table 1) that contained the entire E. cloacae NOR-1 ampD gene.

Recombinant DNA techniques and complementation experiments. Recombinant DNA techniques were performed mostly by standard procedures (36). Whole-cell DNAs from E. cloacae WT NOR-1 and ceftazidime-resistant E. cloacae NOR-1D mutants were prepared as previously described (27). The restriction enzymes, Klenow DNA polymerase, and ligase were from Amersham Pharmacia Biotech. The Pfu thermostable DNA polymerase was from Stratagene. Ligation products were subjected to electroporation into E. coli or E. cloacae strains according to the manufacturer's instructions (Gene Pulser II; Bio-Rad). Recombinant bacteria were plated onto TS agar plates containing the appropriate antibiotic. Recombinant plasmid DNAs were prepared using Qiagen Mini and Maxi columns (Qiagen) (34). Plasmids were subsequently electroporated into the appropriate host (Table 1). Fragment sizes were estimated by comparison to the molecular size standard 1-kb DNA ladder (Life Technologies).

The ampD genes of E. cloacae WT NOR-1 and of 11 ceftazidime-resistant E. cloacae NOR-1D strains were PCR amplified using the Pfu thermostable polymerase (Stratagene). The two primers used were AmpD-RBS, which created a consensus ribosomal binding site (RBS) 5 bp upstream of the ATG start codon (AmpD-RBS; 5'-AAGGAGGATAC CATGTTGTTAGAAAACGGATGGC-3') and AmpD-H3, which matched to the end of the ampD gene (AmpD-H3; 5'-AAAAAGCTTTCATGTTA-TCTCCTTATCTGACG-3'). These PCR fragments were then cloned into pPCRScript, downstream of the lac promoter, yielding plasmids pMS1right-arrow 12 (plasmids pMS1 to pMS12) that contained the mutated ampD1right-arrow 12 (ampD1 to ampD12) alleles and pMS13 that contained the WT ampD allele (Table 1). The sequences of the cloned PCR-generated DNA fragments were confirmed by complete resequencing.

Plasmids pPTN-3, pPTN-7, and pPTN-9 were constructed by cloning a 2.2-kb NaeI fragment of plasmid pPTN-1 (26) into a SmaI-digested pK19 plasmid, a blunt-ended BamHI site of pACYC184 plasmid, and a SmaI-digested pGB2 plasmid, respectively (Table 1). The recombinant plasmids were then used in induction experiments in host E. coli strains.

Nucleotide sequence accession number. The nucleotide sequence data reported in this paper will appear in the GenBank-EMBL-DDBJ nucleotide databases under the accession nos. AF298868 to AF298879.


    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

Mutant selection and analysis of their biochemical properties. Twelve independent E. cloacae NOR-1 cultures were grown in 10-ml portions of TS broth for 16 h and were subsequently plated on ceftazidime-containing TS plates. An average of 10 to 100 colonies per 109 plated bacteria grew, resulting in a mutation frequency of 10-7 to 10-8. From each independent experiment, the antibiotic susceptibility of three colonies was checked on a routine antibiogram. In addition to the usual phenotype observed in E. cloacae of a derepressed cephalosporinase expression, the inhibition zone around the imipenem disk was reduced, suggesting that the expression of the carbapenem-hydrolyzing beta -lactamase NmcA might also have been modified. Furthermore, clavulanic acid restored part of the susceptibility to imipenem. One clone was retained for further analysis from each independent experiment. Subsequently, the MICs of selected beta -lactams for the 12 ceftazidime-resistant strains of E. cloacae NOR-1D1right-arrow 12 (strains NOR-1D1 to NOR-1D12) and the E. cloacae WT NOR-1 strains were determined. The ceftazidime and imipenem MICs confirmed the antibiogram observations (see Table 4).

In order to investigate the molecular mechanism of this increased imipenem resistance, enzymatic assays were performed with and without induction. The results clearly indicated that when cephalothin, which is a substrate of both the AmpC and NmcA beta -lactamases (Table 2) was used, an increase in the specific activity of more than 1,000-fold was observed in the mutant strains compared to that of the WT strain. Furthermore, the mutants lost their ability of induction and had a high level of constitutive beta -lactamase expression. When imipenem was used as a substrate, merely the activity of the carbapenem-hydrolyzing beta -lactamase NmcA was measured. Again, the mutants had an increased specific activity towards imipenem (500-fold) with a loss of induction. Interestingly, E. cloacae NOR-1D3 had only a partially derepressed expression of NmcA that was still induced (Table 2). Thus, the induction and derepression of NmcA seemed to follow the same regulation pathway as observed for cephalosporinase. In order to verify this hypothesis, the ampD genes of the mutants were sequenced and compared to the WT ampD gene.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   beta -Lactamase specific activities from cultures of WT and ceftazidime-resistant E. cloacae NOR-1 strains

Cloning and sequencing of the ampD alleles. Nucleotide sequence comparison revealed significant divergence between E. cloacae ampD genes similar to that found among the Citrobacter freundii ampD genes (40). The deduced amino acid sequence of E. cloacae NOR-1 AmpD exhibited 95, 91, 83, 82, 56, and 52% identity with AmpD of E. cloacae O29 (9), E. cloacae 14 (18), E. coli (13), C. freundii OS60 (18), Pseudomonas aeruginosa (21) and with the putative Haemophilus influenzae AmpD protein (10), respectively. Amino acid sequence alignment of the AmpD proteins revealed several conserved motifs (Fig. 1). The conserved core region and the four strictly conserved residues outside this region, which relate the AmpD proteins of members of the family Enterobacteriaceae to the cell wall hydrolases of Bacillus spp. (16), were found in the E. cloacae NOR-1 AmpD. The high degree of identity of the AmpD proteins showed that AmpD of E. cloacae NOR-1 was closely related to its enterobacterial homologs and that they probably share a common mechanism of regulation of AmpC beta -lactamase expression and murein metabolism.


View larger version (63K):
[in this window]
[in a new window]
  		FIG. 1.   Alignment of the AmpD amino acid sequence of E. cloacae NOR-1 (AmpDEcNOR-1) with those of E. cloacae O29 (AmpDEcO29) (9), E. cloacae 14 (AmpDEc14) (18), E. coli (AmpDEcoli) (13), C. freundii OS60 (AmpDCfOS600) (18), and P. aeruginosa (AmpDPa) (21) and a putative H. influenzae (AmpDHi) (10) AmpD protein. The identical amino acids are indicated by asterisks. The crosses and the open diamonds indicate the amino acids conserved in the core and outside region of the Bacillus cell wall hydrolases, respectively. The triangles show the amino acids strictly conserved in various cell wall hydrolases (16). The numbering used corresponds to the E. cloacae AmpD sequences. Amino acid substitutions that alter the activity of the AmpD protein (bold letters on gray shaded background) and mutated positions that yielded stop codons (white letters on black background) are indicated.

Of the 12 ceftazidime-resistant E. cloacae NOR-1D mutants, 3 had single amino acid changes in AmpD. Eight mutations resulted in premature termination of the protein by either creation of a stop codon at the site of mutation or by introducing a frameshift mutation leading to a stop codon located further downstream (Table 3 and Fig. 1). PCR amplification of the ampD gene of E. cloacae NOR-1D7 failed despite the use of different primer combinations. Dot blot hydridization experiments with an internal E. cloacae NOR-1 ampD probe indicated that E. cloacae NOR-1D7 still possessed an ampD gene. However, this gene may be mutated at the site of primer binding or may be partially deleted, thus lacking one primer-binding site. Interestingly, the amino acid substitutions were found in the N terminus of the protein, while the stop codons were mostly located within the C terminus. Sequence data from the literature indicated the importance of the carboxy portion of the AmpD protein for the inducible AmpC phenotype (11). Two mutations in the amino terminus which correlated with a fully derepressed phenotype have been characterized, a valine-to-glycine change at position 33 in E. cloacae (40) and a tryptophan-to-glycine change at position 7 in E. coli (13).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 3.   Amino acid differences among ampD gene products of ceftazidime-resistant E. cloacae NOR-1 mutants

Here, we present further evidence that point mutations within the amino terminus lead to a fully derepressed phenotype for AmpC and NmcA expression. The histidine 34 residue, which is conserved among the AmpD proteins and also among the hydrolases, when replaced by tyrosine led to a fully derepressed phenotype (Fig. 1). A serine-to-leucine replacement at position 73 gave a similar phenotype. This last serine, even though conserved among the AmpD proteins, lies outside the conserved boxes shared with the hydrolases and thus may represent an AmpD-specific amino acid important for its activity. The isoleucine-to-serine substitution at position 48 gave a high basal level and still inducible phenotype. This position is not strictly conserved among AmpD proteins but contains a neutral amino acid residue, which may be involved in the proper folding of the enzyme.

The remaining mutations led to premature termination of AmpD proteins. Even though these mutations were scattered throughout the entire protein sequence, three were located at amino acid position 95. Indeed, of 12 independent mutations, 3 were located at this position. In C. freundii, this position was also found to be a site of mutation (40). The last 16 amino acids are important for the activity of AmpD, since the deletion of these amino acids led to a derepressed phenotype. This observation has been made with an AmpD mutant of E. coli (13). Most mutations identified in the present work were located at positions that have never been reported and were mostly located outside of the known conserved motifs. The 11 ampD mutations identified in this work expand the number of known mutations leading to altered Bush group 1 and 2e beta -lactamase expression (4). They support previous findings demonstrating the essential nature of the carboxy terminus of the mature protein but also revealed key positions at the amino terminus of the protein that are also important for the activity. Mutations introducing stop codons are primarily encountered in the C-terminal portion, while mutations introducing amino acid substitutions are mostly encountered in the N-terminal portion.

In clinical and laboratory isolates of E. cloacae, C. freundii, and P. aeruginosa, several phenotypes of altered beta -lactamase expression have also been described (11, 37). In enterobacteria, three of four phenotypes of altered beta -lactamase expression have been associated with mutations in ampD (3, 9, 13, 18, 23, 40). They include wild-type (normal induction), hyperinducible (higher basal level of AmpC expression and high-level induction in the presence of low levels of inducing drugs), and stably derepressed. In our study, these three phenotypes were found. Kuga et al. have shown that mutations in ampR may also lead to high-level AmpC expression, and the mutation frequency was 10-6 as tested from a plasmid carrying ampC or ampR in an ampD-deficient E. coli strain (20). Since the mutation frequencies of ampD were 10-7 to 10-8, mutations in nmcR and/or ampR of E. cloacae NOR-1 also should have been detected. However, of the 12 mutants studied, all had a mutation in the ampD sequence. Sequencing of nmcR from E. cloacae NOR-1D1 and NOR-1D3 revealed WT sequences (data not shown). nmcR mutations may occur only after ampD mutations and thus may increase the resistance of the strains even more. The frequency of mutation to beta-lactam resistance via mutations in nmcR is probably always at least 10-fold lower than mutations in ampD, since the former type of mutation must not affect the ability of the regulator to interact properly with its target sequence, while any mutations affecting the amidase activity of AmpD will have a phenotype. This issue will be addressed in future investigations. In addition, it is not known whether nmcR mutations have an impact on the expression of a single copy of the nmcA gene present on the chromosome in the absence of an ampD mutation. Using the E. coli host strains and the induction assay based on a low-copy-number plasmid carrying nmcA and nmcR, we will be able to investigate the role of nmcR mutations.

Complementation of ceftazidime-resistant E. cloacae NOR-1 strains. In order to know whether the ampD mutations were responsible for the observed phenotype, the ampD genes were cloned onto a high-copy-number plasmid, resulting in plasmids pMS1right-arrow 12 and tested in transcomplementation experiments. The WT ampD gene of E. coli and E. cloacae NOR-1, as expressed from plasmids pNH5 (13) and pMS-13, respectively, transcomplemented the ceftazidime-resistant E. cloacae NOR-1D strains to low-level beta -lactam resistance (decrease in ceftazidime and imipenem MICs) and restored WT beta -lactamase expression (low basal level and inducibility) (Table 4). The induced/noninduced ratio of beta -lactamase activity was 9.5 in cells producing the E. coli AmpD protein, while in cells expressing the E. cloacae NOR-1 AmpD protein, this ratio was 16. This difference could reflect differences in expression levels of the AmpD proteins or species-specific differences in activity.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 4.   MICs of selected beta -lactams and E. cloacae NmcA specific beta -lactamase activities in different host strains

The 11 mutated ampD alleles failed to restore a low-level and inducible phenotype, indicating that the single ampD mutation was sufficient to inactivate AmpD. The mutated ampD3 allele was capable of partial recovering of an inducible phenotype. These results showed that the cloned WT ampD allele is sufficient to restore the WT NmcA expression level, thus confirming that AmpD is involved in the induction of NmcA.

Similarly, the WT ampD genes of E. coli and E. cloacae NOR-1, as expressed from plasmids pNH5 and pMS-13, respectively, transcomplemented the derepressed E. cloacae MNH2 mutants to low-level beta -lactam resistance and WT beta -lactamase expression (low basal level and inducibility). Taken together, these results clearly showed that the WT AmpD protein was sufficient to restore basal and inducible beta -lactamase expression of NmcA and AmpC beta -lactamases.

Complementation of E. coli ampD mutants. To determine the ability of the E. cloacae NOR-1 ampD gene to complement E. coli ampD mutations, plasmids pSM13 and pSM1right-arrow 12 were transformed into E. coli JRG582 (Delta ampDE) and E. coli MC4100 (ampDE+) (13) containing plasmid pPTN-9. pPTN-9 is a low-copy-number plasmid that carries the nmcA and nmcR genes from E. cloacae NOR-1. E. coli MC4100/pPTN-9 exhibits a high basal beta -lactamase activity and is inducible, while E. coli JRG582/pPTN-9 has a fully derepressed phenotype (Table 4). These two strains were resistant to aztreonam and imipenem (Table 4). The ampD genes of E. coli and E. cloacae, as expressed from pNH5 and pMS-13, respectively, transcomplemented the E. coli ampDE mutant to low-level beta -lactam resistance and WT beta -lactamase expression (low basal level and inducibility) (Table 4). In addition, the 11 mutated alleles of ampD failed to restore an inducible phenotype of carbapenem-hydrolyzing beta -lactamase (data not shown). These results showed that the cloned E. cloacae NOR-1 ampD gene expresses a functional AmpD protein in E. coli cells and that the mutations observed in the ampD gene also account for the observed phenotype in E. coli.

Recombinant plasmids pPTN-3, -7, and -9 carry the same nmcA and nmcR genes but at different copy numbers (Table 1). Induction assays and MICs (Table 4) revealed that beta -lactamase activity was directly related to the plasmid copy number measured. However, the activity increase was not linearly related to the theoretical copy number of the plasmid. Furthermore, the induced/noninduced ratio is conversely related to its theoretical copy number.

Conclusions. In order to determine whether genetic alterations leading to a derepressed NmcA expression phenotype of E. cloacae NOR-1 could be linked to ampD mutations, 12 independent ceftazidime-resistant E. cloacae NOR-1D strains were investigated. Of these 12 strains, 11 had point mutations in the ampD coding sequence leading to nonfunctional AmpD. These results along with the high percentage of identity observed among enterobacterial AmpD proteins strongly suggest that E. cloacae NOR-1 AmpD acts as an N-acetyl-anhydromuramyl-L-alanine amidase, which leads to a decreased amount of anhydromuropeptide (MTp), the signal molecule for beta -lactamase expression (17).

Our data indicate that controls of the induction process are similar for NmcA and AmpC beta -lactamases, suggesting that different structural genes may be under the control of identical regulatory systems. Such an observation has already been made for Aeromonas sobria, where three different beta -lactamase genes are under the same two-component regulatory pathway that is not related to LysR-type regulation (1). It would be interesting to study the regulation of beta -lactamase expression in Yersinia enterocolitica, an enterobacterial species that naturally contains an AmpC-type cephalosporinase and an Ambler class A beta -lactamase (38, 39).

Finally, from a clinical point of view, our results showed that treatment with ceftazidime might select strains that are resistant to all available beta -lactams through a single genetic event affecting the expression of two unrelated broad-spectrum beta -lactamases.


    ACKNOWLEDGMENTS

This work was funded in part by grants from the Ministères de l'Education Nationale et de la Recherche and the Université Paris XI (grant UPRES-JE 2227), Paris, France.


    FOOTNOTES

* Corresponding author. Mailing address: Service de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94275 Le Kremlin-Bicêtre Cedex, France. Phone: 33-1-45-21-20-19. Fax: 33-1-45-21-63-40. E-mail: thierry.naas{at}kb.u-psud.fr.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

1. Alksne, L. E., and B. A. Rasmussen. 1997. Expression of the AsbA1, OXA-12, and AsbM1 beta -lactamases in Aeromonas jandaei AER 14 is coordinated by a two-component regulon. J. Bacteriol. 179:2006-2013[Abstract/Free Full Text].
2. Ambler, R. P., A. F. Coulson, J.-M. Frère, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Lévesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A beta-lactamases. Biochem. J. 276:269-270.
3. Bennett, P. M., and I. Chopra. 1993. Molecular basis of beta -lactamase induction in bacteria. Antimicrob. Agents Chemother. 37:153-158[Free Full Text].
4. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for beta -lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233[Medline].
5. Chang, A. C. Y., and S. N. Cohen. 1978. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from p15A cryptic miniplasmid. J. Bacteriol. 134:1141-1156[Abstract/Free Full Text].
6. Churchward, G., D. Belin, and Y. Nagamine. 1984. A pSC101-derived plasmid which shows no sequence homology to other commonly used cloning vectors. Gene 31:165-171[CrossRef][Medline].
7. Datz, M., B. Joris, E. A. M. Azab, M. Galleni, J. Van Beeumen, J.-M. Frère, and H. H. Martin. 1994. A common system controls the induction of very different genes: the class-A beta -lactamase of Proteus vulgaris and the enterobacterial class-C beta -lactamase. Eur. J. Biochem. 226:149-157[Medline].
8. Dietz, H., D. Pfeifle, and B. Wiedemann. 1997. The signal molecule for beta -lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob. Agents Chemother. 41:2113-2120[Abstract].
9. Ehrhardt, A. F., C. C. Sanders, J. R. Romero, and J. S. Leser. 1996. Sequencing and analysis of four new Enterobacter ampD alleles. Antimicrob. Agents Chemother. 40:1953-1956[Abstract].
10. Fleischmann, R. D., M. D. Adams, O. White, et al. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512[Abstract/Free Full Text].
11. Hanson, N. D., and C. C. Sanders. 1999. Regulation of inducible AmpC beta-lactamase expression among Enterobactericeae. Curr. Pharm. Des. 5:881-894[Medline].
12. Höltje, J.-V., U. Kopp, A. Ursinus, and B. Wiedemann. 1994. The negative regulator of beta -lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase. FEMS Microbiol. Lett. 122:159-164[CrossRef][Medline].
13. Honoré, N., M. H. Nicolas, and S. T. Cole. 1989. Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer. Mol. Microbiol. 3:1121-1130[CrossRef][Medline].
14. Jacobs, C., J.-M. Frère, and S. Normark. 1997. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta -lactam resistance in gram-negative bacteria. Cell 88:823-832[CrossRef][Medline].
15. Jacobs, C., L. J. Huang, E. Bartowsky, S. Normark, and J. T. Park. 1994. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta -lactamase induction. EMBO J. 13:4684-4694[Medline].
16. Jacobs, C., B. Joris, M. Jamin, K. Klarsov, J. Van Beeumen, D. Mengin-Lecreulx, J. van Heijenoort, J. T. Park, S. Normark, and J.-M. Frère. 1995. AmpD, essential for both beta -lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase. Mol. Microbiol. 15:553-559[Medline].
17. Jones, M. E., and P. M. Bennett. 1995. Inducible expression of the chromosomal cdiA from Citrobacter diversus NF85, encoding an Ambler class A beta-lactamase, is under similar genetic control to the chromosomal ampC, encoding an Ambler class C enzyme, from Citrobacter freundii OS60. Microb. Drug Resist. 1:285-291[Medline].
18. Kopp, U., B. Wiedemann, S. Lindquist, and S. Normark. 1993. Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae. Antimicrob. Agents Chemother. 37:224-228[Abstract/Free Full Text].
19. Korfmann, G., and C. C. Sanders. 1989. ampG is essential for high-level expression of AmpC beta -lactamase in Enterobacter cloacae. Antimicrob. Agents Chemother. 33:1946-1951[Abstract/Free Full Text].
20. Kuga, A., R. Okamoto, and M. Inoue. 2000. ampR gene mutations that greatly increase class C beta -lactamase activity in Enterobacter cloacae. Antimicrob. Agents Chemother. 44:561-567[Abstract/Free Full Text].
21. Langaee, T. Y., M. Dargis, and A. Huletsky. 1998. An ampD gene in Pseudomonas aeruginosa encodes a negative regulator of AmpC beta -lactamase expression. Antimicrob. Agents Chemother. 42:3296-3300[Abstract/Free Full Text].
22. Langaee, T. Y., L. Gagnon, and A. Huletsky. 2000. Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta -lactamase expression. Antimicrob. Agents Chemother. 44:583-589[Abstract/Free Full Text].
23. Lindquist, S., M. Galleni, F. Lindberg, and S. Normark. 1989. Signalling proteins in enterobacterial AmpC beta -lactamase regulation. Mol. Microbiol. 3:1091-1102[Medline].
24. Matsumoto, Y., and M. Inoue. 1999. Characterization of SFO-1, a plasmid-mediated inducible class A beta -lactamase from Enterobacter cloacae. Antimicrob. Agents Chemother. 43:307-313[Abstract/Free Full Text].
25. Miro, E., M. Barthélémy, J. Peduzzi, A. Reynaud, A. Morand, G. Prats, and R. Labia. 1994. Properties of a cephalosporinase produced by Proteus penneri inhibited by clavulanic acid. Pathol. Biol. 42:487-490[Medline].
26. Naas, T., and P. Nordmann. 1994. Analysis of a carbapenem-hydrolyzing class A beta -lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc. Natl. Acad. Sci. USA 91:7693-7697[Abstract/Free Full Text].
27. Naas, T., L. Vandel, W. Sougakoff, D. M. Livermore, and P. Nordmann. 1994. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta -lactamase, Sme-1, from Serratia marcescens S6. Antimicrob. Agents Chemother. 38:1262-1270[Abstract/Free Full Text].
28. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Wayne, Pa.
29. Nicolas, M.-H., N. Honoré, V. Jarlier, A. Philippon, and S. T. Cole. 1987. Molecular genetic analysis of cephalosporinase production and its role in beta -lactam resistance in clinical isolates of Enterobacter cloacae. Antimicrob. Agents Chemother. 31:295-299[Abstract/Free Full Text].
30. Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M.-H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing class A beta -lactamase from Enterobacter cloacae and cloning of its gene into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946[Abstract/Free Full Text].
31. Normark, S. 1995. beta -Lactamase induction in Gram-negative bacteria is intimately linked to peptidoglycan recycling. Microb. Drug Resist. 1:111-114[Medline].
32. Normark, S., E. Bartowsky, J. Erickson, C. Jacobs, F. Lindberg, S. Lindquist, K. Weston-Hafer, and M. Wikström. 1994. Mechanisms of chromosomal beta -lactamase induction in Gram-negative bacteria, p. 485-503. In J.-M. Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Science B.V., Amsterdam, The Netherlands.
33. Peduzzi, J., S. Farzaneh, A. Reynaud, M. Barthélémy, and R. Labia. 1997. Characterization and amino acid sequence analysis of a new oxyimino cephalosporin-hydrolyzing class A beta-lactamase from Serratia fonticola CUV. Biochim. Biophys. Acta 1341:58-70[CrossRef][Medline].
34. Poirel, L., M. Guibert, D. Girlich, T. Naas, and P. Nordmann. 1999. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrob. Agents Chemother. 43:769-776[Abstract/Free Full Text].
35. Pridmore, R. D. 1987. Versatile cloning vectors with kanamycin resistance marker. Gene 56:309-312[CrossRef][Medline].
36. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
37. Sanders, C. C., and W. E. Sanders, Jr. 1992. beta -Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:825-839.
38. Seoane, A., and J. M. Garcia Lobo. 1991. Nucleotide sequence of a new class A beta -lactamase gene from the chromosome of Yersinia enterocolitica: implications for the evolution of class A beta -lactamases. Mol. Gen. Genet. 228:215-220[Medline].
39. Seoane, A., M. V. Francia, and J. M. Garcia Lobo. 1992. Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica. Antimicrob. Agents Chemother. 36:1049-1052[Abstract/Free Full Text].
40. Stapleton, P., K. Shannon, and I. Phillips. 1995. DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob. Agents Chemother. 39:2494-2498[Abstract].
41. Trepanier, S., A. Prince, and A. Huletsky. 1997. Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator. Antimicrob. Agents Chemother. 41:2399-2405[Abstract].

Antimicrobial Agents and Chemotherapy, October 2001, p. 2908-2915, Vol. 45, No. 10
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.10.2908-2915.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Yang, T.-C., Huang, Y.-W., Hu, R.-M., Huang, S.-C., Lin, Y.-T. (2009). AmpDI Is Involved in Expression of the Chromosomal L1 and L2 {beta}-Lactamases of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 53: 2902-2907 [Abstract] [Full Text]  
  • Walther-Rasmussen, J., Hoiby, N. (2007). Class A carbapenemases. J Antimicrob Chemother 60: 470-482 [Abstract] [Full Text]  
  • Radice, M., Power, P., Gutkind, G., Fernandez, K., Vay, C., Famiglietti, A., Ricover, N., Ayala, J. A. (2004). First Class A Carbapenemase Isolated from Enterobacteriaceae in Argentina. Antimicrob. Agents Chemother. 48: 1068-1069 [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naas, T.
Right arrow Articles by Nordmann, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naas, T.
Right arrow Articles by Nordmann, P.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»